Ross Margulies

Associate - Washington, D.C.

Bio photo for Ross Margulies
Download Media Photo

Contact Information

Ross Margulies helps innovative healthcare and life sciences companies to advance their strategic business goals in a heavily regulated industry undergoing rapid change and disruption. His clients include community health centers, healthcare startups, biopharmaceutical manufacturers, long-term care providers, pharmaceutical benefit managers, pharmacies, large health systems, insurers and technology companies. Ross has a special expertise in helping his clients navigate complex issues related to the Medicaid program at both the State and Federal levels. 

More »


  • George Washington University Law School, J.D., with honors, 2011
  • George Washington University School of Medicine and Health Sciences, M.P.H., 2011
  • McGill University, B.A., magna cum laude, 2007



Foley Hoag Alerts & Updates


  • ABA-BNA Award For Excellence in the Study of Health Law


  • American Health Lawyers Association, Member
  • Health Care Compliance Association, Member
  • DC Bar Association
  • Tennessee Bar Association
  • Chair of the Board of Directors of Certified Naturally Grown

  • Speaker, “Drug Pricing Reforms: The Impossible, Possible and Probable," AHLA’s Institute for Health Plan Law and Compliance Institute  (November 2019)
  • Speaker, “Deep Dive I: Perspectives on State and Federal Medicaid Policies,“ American Society of Gene & Cell Therapy [ASGCT] Policy Summit (November 2019) 
  • Speaker, “The Times They Are a-Changin” – A look at Congressional Efforts to Reform the Medicare and Medicaid Prescription Drug Programs, AMCP Nexus 2019 (October 2019)   
  • Speaker, "Keynote Legal Perspective: The Drug Pricing Landscape – A Survey of Current and Future Legal and Regulatory Reforms," 11th Annual Managed Markets and Account Management Strategies Conference (September 2019)  
  • Speaker, “Assess Potential for Changes to Pharmaceutical Pricing, Discounting, and Reimbursement for the Future,” 2019 CBI  7th Annual Reimbursement and Access (August 2019) 
  • Speaker, "A Federal and State Legislative and Regulatory Update for the Home Care Aide Council," Home Care Aide Council Annual Spring Conference (June 2019)
  • “HHS’ Rule To Change AKS Safe Harbor Protection for Rebates in the Drug Supply Chain," Webinar (April 2019)
  • Speaker, "Navigate the Legal Underpinnings of Patent Assistance and Gain Insight on OIG Oversight," PAP2019 (March 2019)
  • Speaker, "Medicare and Medicaid Reimbursement Issues for New Emerging Technologies: Spotlight on CAR-T and Other Cell and Gene Therapies," American Health Lawyers’ Association Annual Institute on Medicare and Medicaid Payment Issues Conference (March 2019)
  • Speaker, “Biotech & Pharmaceutical Patient Access Forum,” 2016 CBI PAP Conference (March 2016)
  • "Can State Medicaid Agencies Restrict Access to Life-Saving Therapies Based on Cost?," Webinar (July 2014)
  • Speaker, "After Obamacare – Opportunities and Challenges for Healthcare Investing," Angel Capital Association 2014 ACA Summit (March 2014)
  • "Will the Six Protected Class Rule Become a Thing of the Past?," Webinar (January 2014)
  • Speaker, "Final Regulations under the Mental Health Parity and Addiction Equity Act: Substance, Legal Implications and Compliance," American Bar Association webinar (December 2013)
  • Speaker, "Assuring Patient Access to Treatments," U.S. Conference on Rare Diseases & Orphan Products: The New Era in Health Care (October 2013)
Add to Bio Folder

Download Bio

Bar Admissions

  • District of Columbia
  • Maryland